Feb 5 (Reuters) - Aralez Pharmaceuticals Inc:
* Pozen and Tribute combine to create Aralez Pharmaceuticals Inc
* Announced the completion of the business combination of POZEN
Inc and Tribute Pharmaceuticals Canada Inc
* Deal includes $350 million capital commitment from
Deerfield-led Syndicate
* As of closing, Aralez has approximately 75 million outstanding
shares on a fully diluted basis
* Each Pozen share converted into right to receive one Aralez
share and each share of Tribute exchanged for 0.1455 Aralez shares
* Combined company will operate under Aralez
Pharmaceuticals Inc
* Commencing on or about February 8, 2016, Aralez will trade on
NASDAQ under the ticker symbol "ARLZ"
* Source text for Eikon ID:nPn11SDGy
* Further company coverage POZN.O